The FDA said today that it had approved dulaglutide, Lilly’s once-weekly injection to control blood sugar in adults with type 2 diabetes. The drug will be marketed under the brand name of Trulicity. … Click here to read the full post on Forbes. …
One-stop source for cardiology news and links
The FDA said today that it had approved dulaglutide, Lilly’s once-weekly injection to control blood sugar in adults with type 2 diabetes. The drug will be marketed under the brand name of Trulicity. … Click here to read the full post on Forbes. …
Developed By: SKSDEV
"I’d rather read Larry Husten on clinical trials than the constipated editorials in peer review journals." --Saurabh Jha (The Health Care Blog)
Copyright © 2023 · Prose on Genesis Framework · WordPress · Log in
Recent Comments